Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2010
05/05/2010CN101031298B Medicine with analgesic function
05/05/2010CN101023119B Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient
05/05/2010CN101023079B Substituted hydantoins for the treatment of cancer
05/05/2010CN101022800B Pharmaceutical composition for the treatment of bone fracture
05/05/2010CN101001629B Medicinal composition
05/04/2010USRE41315 Modulators of dopamine neurotransmission
05/04/2010US7709669 Aspirin-triggered lipid mediators
05/04/2010US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia
05/04/2010US7709649 Multi-substituted pyridyl sulfoximines and their use as insecticides
05/04/2010US7709647 Antagonists or inverse agonists of the CB-1 receptor; metabolic and eating disorders, dementia, substance abuse; e.g. N-(1-benzyl-6-(4-fluorophenyl)-1,2,3,4-tetrahydroquinolin-3-yl)-3-phenylpropanamide
05/04/2010US7709642 Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
05/04/2010US7709640 Inhibitors of phosphorylation of platelet derived growth factor receptor
05/04/2010US7709631 making a periodate bioresorbable oxidized biocellulose; for human tissue substitutes, closure reinforcement, suture buttressing, guided tissue regeneration, musculoskeletal applications, active agent delivery and tissue engineering scaffolds
05/04/2010US7709630 hybridizable with nucleic acids encoding connective tissue growth factor to modulate the expression of connective tissue growth factor in cells; diabetes
05/04/2010US7709617 Derivatized with a glycerol linker, 2'-deoxy-7-deazaguanosine and arabinoguanosine; immunomer is self-complementary; anticarcinogenic, antiinflammatory, antiallergen, antihistamine, and bronchodilator agents; asthma, skin disorders
05/04/2010US7709616 Micrornas and uses thereof
05/04/2010US7709539 has been shown to have free radical scavenging, anti-inflammatory and anti-thrombogenic activities in biological systems; resveratrol has also been shown to be a good cancer preventive chemical and has been recommended as a food supplement for health benefits; can effectively lower blood sugar
05/04/2010US7709538 Treating tumors by administering the octasodium salt of the tetrameric cyclic compound of 4,5-dihydroxynaphthalene-2,7, disulfonic acid linked by methylene bridges; inhibits the secretion of matrix metalloproteinase by endothelial cells
05/04/2010US7709537 Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials
05/04/2010US7709535 Androgen receptor antagonists; certain cancers such as colon, skin and prostate cancer, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired
05/04/2010US7709534 administration to an infected individual of a C8-C16-alpha,beta-unsaturated aliphatic aldehyde, in particular E-2-dodecenal
05/04/2010US7709533 Imines as ion channel modulators
05/04/2010US7709532 administering a drug consisting of (2S,4S,5S,7S)-5-amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-enzyl]-8-methyl-nonanoic acid (2-arbamoyl-2-methyl-propyl)-amide hemifumarate and efflux protein inhibitor
05/04/2010US7709530 rat poison baits comprising flour, ground biscuit, preservatives, triethanolamine, palm oil, saccharine, sugar, brodifacoum, denatonium benzoate; enticing ingesting effect
05/04/2010US7709529 Treatment of cancer with glutamine
05/04/2010US7709528 Compounds, their preparation and use
05/04/2010US7709527 2-acetyloxy-1-methylpropyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate; Parkinson's disease; crystalline forms; improved pharmacokinetics; oral administration
05/04/2010US7709526 Use of cyclolignans and new cyclolignans
05/04/2010US7709525 Chroman-derived anti-androgens for treatment of androgen-mediated disorders
05/04/2010US7709524 ammonium trichloro(dioxyethylene-O,O')tellurate; epilepsy, inflammatory bowel disease, Crohn's disease and ulcerative colits
05/04/2010US7709523 Alpha-aminoamide derivatives useful as antimigraine agents
05/04/2010US7709522 Kappa selective opioid receptor antagonist
05/04/2010US7709521 Substituted indole derivatives for pharmaceutical compositions for treating respiratory diseases
05/04/2010US7709520 Diindolylmethane and C-substituted diindolylmethane compositions and methods for the treatment of multiple cancers
05/04/2010US7709519 2-(1,3-Dihydro-2H-benzimidazol-2-ylidene)-1-[3-(1,2-dihydroxyethyl)phenyl]-3-(3,4,5-trifluorophenyl)propane-1,3-dione; GnRH receptor antagonism; prostate cancer, breast cancer, endometriosis, uterine leiomyoma, benign prostatic hypertrophy; good availability by oral administration
05/04/2010US7709518 Compounds for inflammation and immune-related uses
05/04/2010US7709517 N-methyl-4-{4-[7-(4-cyano-3 -trifluoromethylphenyl)-6,8-dioxo-5,7-diazaspiro[3.4]oct-5-yl]-phenyl}butyramide; for treatment of hormone refractory prostate cancer
05/04/2010US7709516 Helix 12 directed non-steroidal antiandrogens
05/04/2010US7709515 Therapy for cardiovascular disorders; dyslipidemia; glucose metabolism disorders; Alzheimer's disease
05/04/2010US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis
05/04/2010US7709513 Benzooxazol-2-one derivatives as lipase and phospholipase inhibitors
05/04/2010US7709511 N-[2-(Diethylamino)ethyl]-N-(2-{[2-(4-hydroxy-2-oxo -2,3-dihydro-1,3-benzothiazol-7-yl)ethyl]amino}ethyl)-3-[2-(1-naphthyl)ethoxy]propanamide; respiratory system disorders
05/04/2010US7709510 Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
05/04/2010US7709509 disorders of lipid and/or carbohydrate metabolism, metabolic disorders, central nervous system disorders; 3-{2-Chloro-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazole-5-one
05/04/2010US7709508 (8R,10aS)-6-(trifluoromethyl)-3,9,10,11-tetrahydro-8,10a-methanocyclohepta[1,2]indeno[4,5-d][1,2,3]triazol-7(8H)-one; uterine fibroid disease, hot flashes, urogenital disorders, inflammation; improved metabolic profile; bone disorders
05/04/2010US7709507 1-[1-(3-chloro-phenyl)-2-phenyl-ethyl]-3-(2-fluoro-ethyl)-urea; for alleviating chronic pain, allodynia, muscle spasticity, diarrhea, neuropathic pain, visceral pain
05/04/2010US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents
05/04/2010US7709505 2-methyl-4-isobutoxy-6-[N-(5-carboxypyridin-2-yl)carbamoyl]benzofuran; 2-methyl-4-isobutoxy-6-[N-(5-carboxypyridin-2-yl)carbamoyl]benzofuran; type 2 diabetes
05/04/2010US7709504 Specific and nonspecific non-adenosine-analogous adenosine receptor agonists suitable as antiemetics; phenyl ring p-substituted with hydroxyethyloxy or acetamido group, sulfur substituted by 2-pyridylmethyl or 2-(p-chlorophenyl)thiazol-5-yl methyl group
05/04/2010US7709503 2-chloro-6-(4-{[(3,4-dichloro-5-methyl-1H-pyrrol-2-yl)carbonyl]amino}piperidin-1-yl)-N-methoxypyrimidine-4-carboxamide; 1-[4-(aminocarbonyl)-6-chloro-2-pyridinyl]4-piperidinyl 4-bromo-5-methyl-1H-pyrrole-2-carboxylate;
05/04/2010US7709502 For reducing levels of tumor necrosis factor alpha in mammals; 3-(1-Oxo-4-aminoisoindolin-1-yl)-3-methylpiperidine-2,6 dione; 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-5-aminoisoindoline
05/04/2010US7709501 Vanilloid receptor ligands and their use in treatments
05/04/2010US7709500 Chemical compounds
05/04/2010US7709497 Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor
05/04/2010US7709496 8-(2-{cis-4-[(2,3-dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]-1-hydroxycyclohexyl}ethyl)-2H-chromen-2-one; may be formulated for administration in any convenient way; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
05/04/2010US7709495 Methods and reagents for the treatment of inflammatory disorders
05/04/2010US7709494 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, method for the production and use thereof as medicaments
05/04/2010US7709493 Tryptophan hydroxylase inhibitors; anticarcinogenic agents; gastrointestinal, cardiovascular, and respiratory system disorders; (S)-2-amino-3-[4-(2-amino-6-{R-1-[4-chloro-2-(3-methyl-pyrazol-1-yl)-phenyl]-2,2,2-trifluoro-ethoxy}-pyrimidin-4-yl)-phenyl]-propionic acid ethyl ester
05/04/2010US7709492 Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
05/04/2010US7709491 {8-Fluoro-2-(4'-fluoro-1,1'-biphenyl-4-yl)-3-[3-trifluoromethyl)phenyl]-3,4-dihydro-4-quinazolinyl}acetic acid; have high antiviral activity
05/04/2010US7709490 use for lowering blood glucose, treating diabetes, or increasing insulin release; 7-(4,5-Diphenylpyrimidin-2-yl)-6-heptynoic Acid
05/04/2010US7709489 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2-a]quinoline-2-carbonyl)-4-methylpiperazine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives
05/04/2010US7709488 2-[2-(4-Methoxypyridin-2-yl)ethyl]-6-[4-(4-methylpiperazin-1-yl-sulfonyl)-phenyl]-3H-imidazo-[4,5-b]pyridine,; acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, organ transplantation and transplant rejection, head trauma, acute lung injury
05/04/2010US7709487 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
05/04/2010US7709486 antiviral compounds 1,4,8,11-tetraazacyclotetradecane derivatives for against HIV-infected cells, to inhibit the binding by the natural ligand to its chemokine receptor; viricides
05/04/2010US7709485 IL-8 receptor antagonists
05/04/2010US7709484 1-((2R,5S)-5-Benzyl-2-naphthalen-2-ylmethyl-piperazin-1-yl)-3-(2,4-dichloro-phenyl)-propan-1-one; melanocortin receptor-associated disorder such as cachexia, obesity, erectile dysfunction or female sexual dysfunction
05/04/2010US7709483 6-({4-[(2,3-Dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]-1-piperidinyl}methyl)-7-fluoro-5,6-dihydro-3H-pyrrolo[1,2,3-de]quinoxalin-3-one; may be formulated for administration in any convenient way for use in human or veterinary medicine
05/04/2010US7709482 Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
05/04/2010US7709481 peroxisome proliferator activator receptor (PPARdelta) agonist; type-2 diabetes, atherosclerosis, cardiovascular disorders; 3-{2-Chloro-4-[4-methyl-2-(1-methyl-cyclohexyl)-oxazol-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazol-5-one
05/04/2010US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer
05/04/2010US7709479 Quinazoline derivatives and their use as pharmaceuticals
05/04/2010US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
05/04/2010US7709477 Triheterocyclic Compounds; small cell lung cancer, follicular lymphoma, non-small cell lung cancer, non-Hodgkin's disease lymphoma, or acute myelocytic leukemia
05/04/2010US7709476 6-Methoxy-3-(methoxymethyl)-2-methyl-4-phenylisoquinolin-1(2H)-one; treat cardiac arrhythmias
05/04/2010US7709475 5-[2-(cyclohexyloxy)-6-methyl-4-pyrimidinyl]-2-[5-(4-methyl-1-piperazinyl)methyl-2-pyrazinyl]amino-1,3-thiazole; anticarcinogenic agent; G1 phase in cell cycle; great selectivity
05/04/2010US7709474 Enantiomerically pure beta agonists, manufacturing and use thereof
05/04/2010US7709473 5-[2-(6-tert-Butyl-3-oxo-2,3-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-ylamino)-ethoxy]-nicotinic acid methyl ester; inhibitors of glycogen synthase kinase 3 (GSK-3); diabetes, dementia, Alzheimer's Disease, bipolar disorder, stroke, schizophrenia, depression, hair loss, cancer
05/04/2010US7709472 treating bacterial infections; 6-{[((1S,5R,6S)-3-{2-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-azabicyclo[3.2.0]hept-6-yl)amino]methyl}-2H-pyrido[3,2-b][1,4]-thiazin-3(4H)-one or -oxazin-3(4H)-one; antibiotics; grampositive Staphylococcus, gramnegative Haemophilus, Moraxella, Escherichia
05/04/2010US7709471 Compounds
05/04/2010US7709470 retinopathy, nephropathy, neuropathy, and hyperlipidemia, obesity, dyslipidemia, and osteoporosis; Retinoid X receptors (RXRs); 4-(2-Cyano-5,7,7,10,10-pentamethyl-7,8,9,10-tetrahydro-5H-5,13-diaza-benzo[4,5]-cyclohepta[1,2-b]naphthalen-12-yl)-2-fluoro-benzoic Acid
05/04/2010US7709469 purinergic receptor inhibitors; 5-[2-chloro-3-(trifluoromethyl)phenyl]-1-[2,3-dihydro-1H-inden-1-yl]-1H-1,2,4-triazole; [4-(2,3-Dichloro-phenyl)-4H-[1,2,4]triazol-3-yl]-(2-pyrrolidin-1-yl-pyridin-3-ylmethyl)-amine
05/04/2010US7709468 Imidazo based heterocycles
05/04/2010US7709467 Apoptosis promoters
05/04/2010US7709466 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals
05/04/2010US7709465 breast cancer, melanoma, colon cancer, leukemia and lymphoma, and other cancer cells
05/04/2010US7709463 Methyl O-(2,3,4-tri-O-methyl-6-O-sulfo- alpha -D-glucopyranosyl)-(1 --> 4)-O-(2,3-di-O-methyl- beta -D-glucopyranosyl uronic acid)-(1 --> 4)-O-(2,3,6-tri-O-sulfo- alpha -D-glucopyranosyl)-(1 --> 4)-O-(2,3-di-O-methyl- alpha -L-idopyranosyl uronic acid)-(1 --> )-2,3,6-tri-O-sulfo- alpha -D-glucopyranoside
05/04/2010US7709461 Administering an aerosol of dry polysaccharide such as heparin of given particle size diameter
05/04/2010US7709460 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality
05/04/2010US7709459 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
05/04/2010US7709458 Method for inhibiting cancer cell proliferation or increasing cancer cell apoptosis
05/04/2010US7709457 treating bladder cancer; transfecting with polynucleotide into urothelial cells; improved transfection efficiency with cationic lipids, cationic polymers or dendrimers; improve drug delivery with a solubilized cholesterol
05/04/2010US7709456 increasing synthesis of a human progesterone receptor transcript in a mammalian cell
05/04/2010US7709453 Modulation of the RNA interference pathway
05/04/2010US7709452 Pharmaceutical composition which improves in vivo gene transfer
05/04/2010US7709451 Method and composition for treating immune complex associated disorders
05/04/2010US7709450 Stimulation of vascularization with VEGF-B-186
05/04/2010US7709449 Treating hepatitis infections, particularly hepatitis B viral infections; modified oligonucleotides
05/04/2010US7709448 Prodrugs of 5-amino-3-(3′-deoxy-β-D-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione
05/04/2010US7709447 Use of spinosyns for wound healing
1 ... 2285 2286 2287 2288 2289 2290 2291 2292 2293 2294 2295 2296 2297 2298 2299 2300 2301 2302 2303 2304 2305 ... 7860